Washington, D.C. – MAY 2, 2025 – New data from a large, international registry showed balloon-assisted anterior mitral leaflet modification (BATMAN) was safe, effective, and resulted in shorter ...

• Is the chordal-sparing mitral valve (MV) replacement (CCS-MVR) procedure effective in functional mitral regurgitation and degenerative mitral valve disease? • Does the CCS-MVR procedure improve left ...

Intentionally tearing the anterior mitral valve leaflet may prevent one of the most serious and life-threatening complications of transcatheter mitral valve replacement (TMVR)—left ventricular outflow ...

WASHINGTON, DC—In patients undergoing transcatheter mitral valve replacement (TMVR), a balloon-assisted technique shows promise as a way of modifying the anterior mitral leaflet to prevent left ...

Posterior mitral valve leaflet aneurysms are extremely rare complications of infective endocarditis of the aortic valve. Destruction of the aortic valve results in a regurgitant jet that strikes the ...

WASHINGTON -- Operators can avoid two feared complications of transcatheter valve replacement with upfront radiofrequency-based laceration of the aortic or mitral leaflets, according to two early ...

Employing intravascular lithotripsy facilitated transcatheter mitral valve replacement in a patient with severe mitral annular and mitral valve leaflet calcification, according to a report on a ...

The M-mode through the aortic valve (Figure 2) demonstrates that the closure of the leaflets during diastole is far from the center of the aorta. This is a common M-mode finding of a bicuspid aortic ...

Background A 67-year-old man was admitted to a coronary care unit for non-ST-segment elevation myocardial infarction with complicating acute heart failure. Severe mitral regurgitation was detected by ...

The findings on this M-mode through the mitral valve are as follows: there is diastolic fluttering of the mitral valve, there is an exaggerated diastolic "dip" of the septum, and there is premature ...

Symetis spinout Polares Medical unlocked $25 million in venture capital financing to continue development of its mitral valve repair/replacement system and enter clinical testing. The Lausanne, ...